zanamivir  - Drug Details
📊 Estimates zanamivir  Dialyzability By Different_Modalities

zanamivir 

Complete Drug Information

Drug Name
zanamivir 
Trade Names
Relenza
Pregnancy Category
AU: B1
Bioavailability
2% (oral)
Routes of Administration
Inhalation, intravenous
Protein Binding
<10%%
Metabolism
Negligible
Elimination
2.5–5.1 hours
Excretion
Kidney
Formula
C12H20N4O7
Molar Mass
332.313
Volume of Distribution
C12H20N4O7

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.